Vancomycin-Resistant Enterococcus: Infectious Endocarditis Treatment

Rybak1, Coyle

  • 1The Anti-Infective Research Laboratory, Department of Pharmacy Services, Detroit Receiving Hospital and University Health Center, 4201 St. Antoine Blvd, Detroit, MI 48201, USA.

Insights

Vancomycin-resistant Enterococcus infections are a serious threat with limited treatment options. New antibiotics like daptomycin show promise for endocarditis, but more research, especially on combination therapies, is crucial.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Vancomycin-resistant Enterococcus (VRE) species are critical gram-positive pathogens.
  • Currently, no definitive therapy is recommended for VRE infections.
  • Emerging antibiotic resistance necessitates novel treatment strategies.

Purpose of the Study:

  • To review the current landscape of antibiotics for VRE infections.
  • To evaluate the potential of new antimicrobial agents for treating VRE endocarditis.
  • To highlight the need for further research into combination therapies.

Main Methods:

  • Review of existing literature on VRE treatment.
  • Analysis of preclinical (animal) and clinical data for novel agents.
  • Assessment of antibiotic efficacy for various VRE infection types.

Main Results:

  • New agents including quinupristin-dalfopristin, LY333328, and daptomycin demonstrate activity against VRE.
  • Limited data suggest potential utility of these agents for VRE endocarditis.
  • Experience with these agents is extensive for other infections but limited for endocarditis.

Conclusions:

  • Quinupristin-dalfopristin, LY333328, and daptomycin may offer therapeutic options for VRE endocarditis.
  • Further investigation is required to establish optimal treatment regimens.
  • Combination therapies are essential to enhance efficacy and mitigate resistance development.

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...